Mind Cure Announces $10.0 Million Bought Deal Financing

Mind Cure Health (CSE: MCUR) this afternoon revealed that it is conducting a bought deal financing. The company is looking to raise gross proceeds of $10.0 million under the financing, with units being sold at $0.60 per each. The financing is being lead by Canaccord Genuity Corp.

Under the terms of the financing, each unit is to consist of one common share and one half warrant. Each warrant is valid for a period of five years from the date of issuance, with an exercise price of $0.80 per share.

An acceleration clause is also present on the warrant, enabling the company to accelerate the expiry of the warrant if the stock trades above $1.50 for a period of ten days on a volume weight basis. The company will also look to list the warrants on the CSE upon closing of the transaction.

An over-allotment option has also been granted to underwriters, valid for a period of 30 days following the close of the financing.

Net proceeds from the financing are to be used for product research, develop, and expansions, to further the firms tech platform including further development of the iSTRYM platform, marketing, and for working capital and general corporate purposes.

Mind Cure Health last traded at $0.75 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

One Response

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Mind Cure Health Appoints Rob Hill To Board Of Directors

Mind Cure Health (CSE: MCUR) this morning announced the appointment of Rob Hill to the...

Monday, February 22, 2021, 09:12:53 AM

Mindcure Ends Fiscal Q1 2022 With $15.6 Million Cash & Cash Equivalents, $2.8 Million Net Loss

Mind Cure Health (CSE: MCUR) announced on Tuesday the financial results for the three months ended...

Wednesday, October 27, 2021, 10:41:00 AM

Mind Cure Appoints Dr Ryan Hartwell As Chief Science Officer

Mind Cure Health (CSE: MCUR) has a new executive. The company this morning announced that...

Tuesday, November 10, 2020, 08:57:19 AM

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics...

Tuesday, March 9, 2021, 08:43:32 AM

Mind Cure To See Nootropics Sold Across North America Via Body Energy Club

Mind Cure Health (CSE: MCUR) this morning released further plans related to the launch of...

Thursday, December 31, 2020, 09:17:25 AM